Finerenone

Kerendia is indicated to reduce the risk of: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2DM).
cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adult patients with heart failure with left ventricular ejection fraction (LVEF) ≥ 40%.
Do not take if: Who are hypersensitive to any component of this product.
Who are receiving concomitant treatment with strong CYP3A4 inhibitors.
With adrenal insufficiency.

What it is used for

Kerendia is indicated to reduce the risk of:

sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2DM).
cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adult patients with heart failure with left ventricular ejection fraction (LVEF) ≥ 40%.

Side effects, and when to stop

The following serious adverse reactions are discussed elsewhere in the labeling:

Hyperkalemia

Who should not take it

Kerendia is contraindicated in patients:

Who are hypersensitive to any component of this product.
Who are receiving concomitant treatment with strong CYP3A4 inhibitors.
With adrenal insufficiency.

Storing it

Store at 20°C to 25°C (68°F to 77°F); excursions are permitted from 15°C to 30°C (59°F to 86°F ).

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Finerenone; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/finerenone
APA 7th: sofidex. (2026, August 2). Finerenone. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/finerenone
AMA 11th: Finerenone. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/finerenone

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.